VEGFA and endothelial dysfunction: For example, bevacizumab (anti-vascular endothelial growth factor) can induce endothelial dysfunction along with decreased nitric oxide bioavailability causing an increase in the vascular tone which contributes to the elevation of blood pressure [21].